The final conference of the TB-REP 2.0 Project aims to enable country stakeholders and partners to take stock of the progress made in project countries, celebrate champions and successes, review the TB-REP 2.0 contribution and challenges encountered, and discuss needs and opportunities for the future.

Virtual regional webinar on the Tools for Use in TB Planning and Programming: Patient Pathway Analysis (PPA) in Four Countries of Eastern Europe and Central Asia organized by the World Health Organization and Center for Health Policies and Studies (PAS Center) on 03 December 2021 within the Global Fund supported TB in Eastern Europe and Central Asia Project on Advancing People-Centered Quality TB Care – From the New Model of Care Towards Improving DR-TB Early Detection and Treatment Outcomes (TB-REP 2.0).

High level on-line event on presenting the Standardized Package of Community-Based Support Services to Improve TB Outcomes, developed by the TB Europe Coalition together with the PAS Center and WHO Regional Office for Europe within the TB-REP 2.0 project.

Oнлайн-семинар по поддержке вовлечения ОГО и сообществ в ключевые направления деятельности в рамках перехода к модели противотуберкулезной помощи, ориентированной на нужды людей, в регионе ВЕЦА. Cеминар, организован 3 сентября 2021 года Европейской коалицией по борьбе с туберкулёзом в сотрудничестве с Центром PAS и Европейским региональным бюро ВОЗ.

Participants discussed the multifaceted aspects of the problem related to the procurement of anti-tuberculosis drugs that countries face in the process of transitioning to public funding, and looked into the possible solutions, including participation in joint procurement through international platforms. A regional overview of the priority issues in this area was presented by an expert of the Curatio International Foundation, Tamar Gotsadze. Representatives from two countries - Uzbekistan and Armenia, presented their experience in procurement of anti-tuberculosis drugs on international platforms.

Tuberculosis control requires a collaborative effort of all actors: health care workers, researchers, private companies, politicians, and people affected by TB. The main objective of the symposium for NGOs is to discuss with communities and civil society the research priorities from the perspective of people affected by TB. Symposium’ topics cover new diagnostic methods and new treatments for TB, tuberculosis health services, and strategies for engaging the communities in the research. The symposium is organized as a joint collaboration of INNOVA4TB and TB-REP 2.0 projects, with special invited speakers from WHO EURO Office.

Webinar of the Collaborative Network to assure access to modern DR-TB medicines on Practical implementation of the active TB drug-safety monitoring and management. Participants discussed regulatory aspects and key steps on implementing aDSM, two countries – Belarus and Kazakhstan shared their experience.

As part of the series of webinars on budget advocacy in the area of HIV and TB, the meeting was organized through cooperation between two regional programs – TB-REP 2.0 (with the support of the Center for Health Policies and Studies and TB Europe Coalition and SoS Project (with the support of ICF Alliance for Public Health and Institute of Analysis and Advocacy).

As part of the series of webinars on budget advocacy in the area of HIV and TB, the meeting was organized through cooperation between two regional programs – TB-REP 2.0 (with the support of the Center for Health Policies and Studies and TB Europe Coalition and SoS Project (with the support of ICF Alliance for Public Health and Institute of Analysis and Advocacy).

As part of the series of webinars on budget advocacy in the area of HIV and TB, the meeting was organized through cooperation between two regional programs – TB-REP 2.0 (with the support of the Center for Health Policies and Studies and TB Europe Coalition and SoS Project (with the support of ICF Alliance for Public Health and Institute of Analysis and Advocacy)

As part of the series of webinars on budget advocacy in the area of HIV and TB, the meeting was organized through cooperation between two regional programs – TB-REP 2.0 (with the support of the Center for Health Policies and Studies and TB Europe Coalition and SoS Project (with the support of ICF Alliance for Public Health and Institute of Analysis and Advocacy)

The communities, rights, and gender (CRG) regional overview ‘Breaking the silence: human rights, gender, stigma and discrimination barriers to TB to TB services in EECA region’ was developed as part of the multi-country program “Advancing People-Centered Quality TB Care - From the New Model of Care Towards Improving DR-TB Early Detection and Treatment Outcomes” (TB-REP 2.0), financed by The Global Fund to Fight AIDS, Tuberculosis and Malaria and implemented by the Center for Health Policies and Studies (PAS Center) as the principal recipient.

First webinar of the Collaborative Network (group on Pharmaceutical regulatory systems) dedicated to pharmaceutical products registration and access to modern DR-TB medicines.

From 2016 to date several communities, rights and gender (CRG) assessments and reviews were conducted in Eastern Europe/Central Asia (EECA) countries: Georgia, Kazakhstan, Kyrgyzstan, Tajikistan and Ukraine.

Community led monitoring via OneImpact App. has been initiated in 4 TB-REP countries to register barriers faced by TB patients, provide real time case by case support and generate data for NTP and local authorizes to inform systemic changes.

On September 23, Valentina Vilc, coordinator of the National Tuberculosis Program of the Republic of Moldova, shared the experience of Moldova in accelerating VOT implementation at the meeting of the WHO Regional Office for Europe with leaders and partners from National Programs on Tuberculosis, HIV infection and viral hepatitis control.

At the regional meeting of the WHO Regional Office for Europe Stella Bivol, Director of PAS Center, presented an overview of the risk assessment conducted within the framework of TB REP 2.0 project concerning the impact of COVID-19 pandemic on the continuity of tuberculosis control program in nine countries of the EECA region.